CT Analysis Algorithms Highly Accurate in COVID-19 Detection
|
By MedImaging International staff writers Posted on 12 May 2020 |

Image: AI can aid radiologists rapidly detect COVID-19 (Photo courtesy of RADLogics)
A novel artificial intelligence (AI) algorithm supports chest computed tomography (CT) imaging for COVID-19 patients.
The RADLogics (Tel Aviv, Israel) algorithms apply machine learning image analysis and interpretation to automatically detect, quantify, and track COVID-19 via non-contrast thoracic CT exams. The AI-based image analysis outputs a suggested “corona score” in order to measure progression of a patients’ disease. For time analysis, the algorithm measures smaller opacities and visualizes larger opacities in a slice-based heat map or in a three dimensional (3D) volume display. The algorithms are easily integrated in both in-house and via a workflow platform that uses Amazon Web Services (AWS) to process up to one million CT studies per day.
In a study involving 157 patients with and without COVID-19 at Mount Sinai Health System (New York, NY, USA) and other institutions, the CT image analysis algorithms, developed from multiple international datasets, were able to differentiate COVID-19 with 98.2% sensitivity and 92.2% specificity. According to the researchers, rapidly screening and evaluating high volumes of thoracic CT imaging studies can assist healthcare systems by augmenting radiologists and acute care teams that could be overwhelmed with patients.
“We’ve seen incredibly strong demand from healthcare systems and providers around the world. Our system has enabled these hospitals to enhance their ability to manage symptomatic patients, especially those with severe or worsening respiratory status,” said Moshe Becker, CEO and co-founder of RADLogics. “Our solution improves patient care by providing doctors with a ‘Corona Score’ that provides clinicians automatic measurements of disease extent of COVID-19 patients, allowing doctors to better manage a patient’s treatment.”
“Current epidemics are calling for new healthcare management approaches, and effective clinical management depends more on disease severity than on the virus identification,” said Sergey Morozov, MD, PhD, MPH, CEO of the Moscow Diagnostics and Telemedicine Center (Russia). “We are looking forward to integrating RADLogics’ AI-powered solution across our hospital network throughout Moscow where imaging plays a crucial role in patient management, specifically chest CT. It allows defining symptomatic patients and stratifying them into mild, moderate, and severe disease burden groups.”
COVID-19 typically manifests with bilateral ground-glass and consolidative pulmonary opacities on CT. Nodular opacities, crazy-paving pattern, and a peripheral distribution of disease may be additional features helpful in early diagnosis. On the other hand, lung cavitation, discrete pulmonary nodules, pleural effusions, and lymphadenopathy are characteristically absent.
Related Links:
RADLogics
The RADLogics (Tel Aviv, Israel) algorithms apply machine learning image analysis and interpretation to automatically detect, quantify, and track COVID-19 via non-contrast thoracic CT exams. The AI-based image analysis outputs a suggested “corona score” in order to measure progression of a patients’ disease. For time analysis, the algorithm measures smaller opacities and visualizes larger opacities in a slice-based heat map or in a three dimensional (3D) volume display. The algorithms are easily integrated in both in-house and via a workflow platform that uses Amazon Web Services (AWS) to process up to one million CT studies per day.
In a study involving 157 patients with and without COVID-19 at Mount Sinai Health System (New York, NY, USA) and other institutions, the CT image analysis algorithms, developed from multiple international datasets, were able to differentiate COVID-19 with 98.2% sensitivity and 92.2% specificity. According to the researchers, rapidly screening and evaluating high volumes of thoracic CT imaging studies can assist healthcare systems by augmenting radiologists and acute care teams that could be overwhelmed with patients.
“We’ve seen incredibly strong demand from healthcare systems and providers around the world. Our system has enabled these hospitals to enhance their ability to manage symptomatic patients, especially those with severe or worsening respiratory status,” said Moshe Becker, CEO and co-founder of RADLogics. “Our solution improves patient care by providing doctors with a ‘Corona Score’ that provides clinicians automatic measurements of disease extent of COVID-19 patients, allowing doctors to better manage a patient’s treatment.”
“Current epidemics are calling for new healthcare management approaches, and effective clinical management depends more on disease severity than on the virus identification,” said Sergey Morozov, MD, PhD, MPH, CEO of the Moscow Diagnostics and Telemedicine Center (Russia). “We are looking forward to integrating RADLogics’ AI-powered solution across our hospital network throughout Moscow where imaging plays a crucial role in patient management, specifically chest CT. It allows defining symptomatic patients and stratifying them into mild, moderate, and severe disease burden groups.”
COVID-19 typically manifests with bilateral ground-glass and consolidative pulmonary opacities on CT. Nodular opacities, crazy-paving pattern, and a peripheral distribution of disease may be additional features helpful in early diagnosis. On the other hand, lung cavitation, discrete pulmonary nodules, pleural effusions, and lymphadenopathy are characteristically absent.
Related Links:
RADLogics
Latest General/Advanced Imaging News
- AI Tool Predicts Side Effects from Lung Cancer Treatment
- AI Tool Offers Prognosis for Patients with Head and Neck Cancer
- New 3D Imaging System Addresses MRI, CT and Ultrasound Limitations
- AI-Based Tool Predicts Future Cardiovascular Events in Angina Patients
- AI-Based Tool Accelerates Detection of Kidney Cancer
- New Algorithm Dramatically Speeds Up Stroke Detection Scans
- 3D Scanning Approach Enables Ultra-Precise Brain Surgery
- AI Tool Improves Medical Imaging Process by 90%
- New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
- AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
- Cutting-Edge Angio-CT Solution Offers New Therapeutic Possibilities
- Extending CT Imaging Detects Hidden Blood Clots in Stroke Patients
- Groundbreaking AI Model Accurately Segments Liver Tumors from CT Scans
- New CT-Based Indicator Helps Predict Life-Threatening Postpartum Bleeding Cases
- CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
- First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
Channels
Radiography
view channel
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read moreMRI
view channel
Ultra-Detailed Brain Atlas Enhances Early Detection of Neurological Disorders
Precise localization of small and deep brain structures remains a hurdle for radiology and neurosurgical planning. Limited resolution in many magnetic resonance imaging atlases constrains segmentation... Read more
Study Finds Advanced Imaging Significantly Reduces Unnecessary Prostate Biopsies
Many men with suspected prostate cancer face an invasive biopsy when magnetic resonance imaging (MRI) is inconclusive. Biopsies can be uncomfortable, carry risks, and may contribute to overdiagnosis and... Read moreUltrasound
view channel
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read more
Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
Rapid and accurate imaging is essential for diagnosing life-threatening conditions such as myocardial infarction, heart failure, and pulmonary embolism. However, conventional ultrasound imaging of the... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







